NCT02224599 2020-04-24
Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies
Kiromic BioPharma Inc.
Phase 1/2 Terminated
Kiromic BioPharma Inc.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain